A biotech company developing tissue-targeted medicines by pairing AI-guided protein design with massively multiplexed in vivo screening.
Manifold Bio
Released September 28, 2025
De novo VHH nanobody binder design that conditions AlphaFold-Multimer with structural templates and language model sequence priors, no retraining.